An outcome comparison between primary liver transplantation and retransplantation based on the pretransplant MELD score

Transplant International

Volumn 19, Issue 4, 2006, Pages 282-287

  Onaca, Nicholas ^a   Levy, Marlon F ^a   Ueno, Takehisa ^a   Martin, Adrian P ^a   Sanchez, Edmund Q ^a   Chinnakotla, Srinath ^a   Randall, Henry B ^a   Dawson III, Sherfield ^a   Goldstein, Robert M ^a   Davis, Gary L ^a   Klintmalm, Goran B ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Liver; Liver transplantation; MELD score; Retransplantation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MODEL FOR END STAGE LIVER DISEASE SCORE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OUTCOME ASSESSMENT (HEALTH CARE); REOPERATION; SURVIVAL RATE;

EID: 33645377941     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00281.x     Document Type: Article

References (45)

1. Wiesner R Edwards E Freeman R et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003 124 91.
2. Botta F Giannini E Romagnoli P et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003 52 134.
3. Brown Jr RS. Kumar KS Russo MW et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in united network for organ sharing status 2a patients. Liver Transpl 2002 8 278.
4. Sheth M Riggs M Patel T. Utility of the mayo end-stage liver disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002 2 2.
5. Wiesner RH McDiarmid SV Kamath PS et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001 7 567.
6. Forman LM Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo end-stage liver disease. Hepatology 2001 33 473.
7. Kamath PS Wiesner RH Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001 33 464.
8. Merion RM. When is a patient too well and when is a patient too sick for a liver transplant Liver Transpl 2004 10 Suppl. 2 S69.
9. Desai NM Mange KC Crawford MD et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004 77 99.
10. Hayashi PH Forman L Steinberg T et al. Model for end-stage liver disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl 2003 9 737.
11. Jacob M Copley LP Lewsey JD et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004 10 903.
12. Olthoff KM Brown RS Jr. Delmonico FL et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 2004 10 Suppl. 2 A6.
13. Saab S Wang V Ibrahim AB et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003 9 473.
14. Yao FY Saab S Bass NM et al. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology 2004 39 230.
15. Santori G Adorno E Morelli N et al. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation. Transpl Int 2005 18 65.
16. Onaca NN Levy MF Netto GJ et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 2003 3 626.
17. Onaca NN Levy MF Sanchez EQ et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003 9 117.
18. Edwards E Harper A. Does MELD work for relisted candidates Liver Transpl 2004 10 Suppl. 2 0S10.
19. Watt KD Lyden ER McCashland TM. Poor survival after liver retransplantation: is hepatitis C to blame Liver Transpl 2003 9 1019.
20. UK National Transplant Database Retransplantation in the UK and Republic of Ireland, 1987-1996. UKTSSA National Transplant Database. Clin Transpl 1997 11 81
21. Azoulay D Linhares MM Huguet E et al. Decision for retransplantation of the liver: an experience- and cost-based analysis. Ann Surg 2002 236 713.
22. Bilbao I Figueras J Grande L et al. Risk factors for death following liver retransplantation. Transplant Proc 2003 35 1871.
23. Deshpande RR Rela M Girlanda R et al. Long-term outcome of liver retransplantation in children. Transplantation 2002 74 1124.
24. Doyle HR Morelli F McMichael J et al. Hepatic retransplantation - an analysis of risk factors associated with outcome. Transplantation 1996 61 1499.
25. Facciuto M Heidt D Guarrera J et al. Retransplantation for late liver graft failure: predictors of mortality. Liver Transpl 2000 6 174.
26. Fangmann J Ringe B Hauss J Pichlmayr R. Hepatic retransplantation: the Hannover experience of two decades. Transplant Proc 1993 25 1077.
27. Jimenez M Turrion VS Alvira LG Lucena JL Ardaiz J. Indications and results of retransplantation after a series of 406 consecutive liver transplantations. Transplant Proc 2002 34 262.
28. Jimenez M Turrion VS Lucena JL Alvira LG Ardaiz J. Late liver retransplantation versus early liver retransplantation: indications and results. Transplant Proc 2002 34 304.
29. Kim WR Wiesner RH Poterucha JJ et al. Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization. Hepatology 1999 30 395.
30. Markmann JF Markowitz JS Yersiz H et al. Long-term survival after retransplantation of the liver. Ann Surg 1997 226 408.
31. Powelson JA Cosimi AB Lewis WD et al. Hepatic retransplantation in New England - a regional experience and survival model. Transplantation 1993 55 802.
32. Rosen HR Madden JP Martin P. A model to predict survival following liver retransplantation. Hepatology 1999 29 365.
33. Saito S Langnas AN Stratta RJ et al. Hepatic retransplantation: University of Nebraska Medical Center experience. Clin Transplant 1992 46 430.
34. Berenguer M Prieto M Palau A et al. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis. Liver Transpl 2003 9 228.
35. Forman LM. To transplant or not to transplant recurrent hepatitis C and liver failure. Clin Liver Dis 2003 7 615.
36. Ghobrial RM Farmer DG Baquerizo A et al. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Ann Surg 1999 229 824.
37. Roayaie S Schiano TD Thung SN et al. Results of retransplantation for recurrent hepatitis C. Hepatology 2003 38 1428.
38. Potsma R Haagsma EB Peeters PM et al. Retransplantation of the liver in adults: outcome and predictive factors for survival. Transpl Int 2004 17 234.
39. Freeman RB Wiesner RH Edwards E Harper A Merion R Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004 10 7.
40. Freeman Jr RB.. MELD/PELD: one year later. Transplant Proc 2003 35 2425.
41. Biggins SW Terrault NA. Should HCV-related cirrhosis be a contraindication for retransplantation Liver Transpl 2003 9 236.
42. Markmann JF Gornbein J Markowitz JS et al. A simple model to estimate survival after retransplantation of the liver. Transplantation 1999 67 422.
43. Ghobrial RM. Retransplantation for recurrent hepatitis C in the model for end-stage liver disease era: how should we or shouldn't we Liver Transpl 2003 9 1025.
44. Burton JR Jr. Sonnenberg A Rosen HR. Retransplantation for recurrent hepatitis C in the MELD era: maximizing utility. Liver Transpl 2004 10 Suppl. 2 S59.
45. McCashland TM. Retransplantation for recurrent hepatitis C: positive aspects. Liver Transpl 2003 9 S67.